X. Lyu

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

X. Lyu is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in met exon 14 skipping mutations, propensity score diagnostics, and medical genetics.

ORCID

Publications per year

2023–2025

Publications

Effectiveness and safety of tofacitinib<i>versus</i>calcineurin inhibitor in interstitial lung disease secondary to anti-MDA5-positive dermatomyositis: a multicentre cohort study

Wanlong Wu, Bingpeng Guo, Wenjia Sun et al. · European Respiratory Journal · 2025 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study

N. Leighl, Byoung Chul Cho, Sandrine Hiret et al. · Journal of Thoracic Oncology · 2023 · 14 citations · Full text

Medicine, Genetics, Oncology +6

1–2 of 2